Official Title
Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room
Brief Summary

Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.

Completed
COVID-19
Lung Ultrasound
Respiratory Complication

Diagnostic Test: COVID-19 RT-PCR

Polymerase chain reaction tests after reverse transcription for the detection of viral Covid-19 RNA (RT-PCR)

Procedure: lung ultrasound

lung ultrasound is standard practice to diagnose acute respiratory failure in Emergency room

Eligibility Criteria

Inclusion Criteria:

- patients admitted to Emergency Room for suspicion of COVID-19 infection with has a
SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung
ultrasound

Exclusion Criteria:

- patients < 18 years of age or under guardianship or curators,

- pregnancy

- poor echogenicity due to the presence of an acoustic barrier (pneumothorax,
subcutaneous emphysema, etc.)

- patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory
distress syndrome (ARDS))

- chronic interstitial lung disease

- patients who will refuse to give their consent.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

BAR
Amiens, France

Stéphane Bar, MD, Principal Investigator
CHU Amiens

Centre Hospitalier Universitaire, Amiens
NCT Number
Keywords
Covid-19
Lung ultrasound
Respiratory Complication
MeSH Terms
COVID-19